MLAB News and Press, Mesa Laboratories Inc. From 08/06/22

The following slide deck was published by Mesa Laboratories, Inc. in conjunction with their 2023 Q1 earnings call. For further details see: Mesa Laboratories, Inc. 2023 Q1 - Results - Earnings Call Presentation

Mesa Laboratories press release ( NASDAQ: MLAB ): Q1 GAAP EPS of -$0.27 misses by $0.27 . Revenue of $50.45M (+44.5% Y/Y) misses by $1.72M . For further details see: Mesa Laboratories GAAP EPS of -$0.27 misses by $0.27, revenue of $50.45M misses by $1.72M...

Cryoport has done well to grow its top line in recent years and some bottom line figures have also fared well. Growth is expected to continue this year, but this doesn't make the company a wise investment. Shares look very expensive right now and are unlikely to offer material ups...

LAKEWOOD, Colo., June 27, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the “Board”), effective June 23, 2022. Tony was previously the Executive Vice President and Chief Financial Officer of ...

Mesa Laboratories press release (NASDAQ:MLAB): Q4 GAAP EPS of -$0.34 misses by $0.82. Revenue of $58.88M (+55.1% Y/Y) beats by $2.58M. For further details see: Mesa Laboratories GAAP EPS of -$0.34 misses by $0.82, revenue of $58.88M beats by $2.58M

Mesa Laboratories (NASDAQ:MLAB) had declared $0.16/share quarterly dividend, in line with previous. Payable June 15; for shareholders of record May 31; ex-div May 27. See MLAB Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Mesa Laboratories goes ex...

Dividend yield of more than 8% is expected from Royce Value Trust. Dividend growth model valuation projects much higher upside than downside. Valuation and dividend grades are upper tier, mainly in the Grade A and Grade B region. Focus on small cap, value stocks provides a lon...

Mesa Laboratories press release (NASDAQ:MLAB): Q3 Non-GAAP EPS of $1.36 beats by $0.04. Revenue of $54.69M (+60.1% Y/Y) beats by $10.22M. For further details see: Mesa Laboratories Non-GAAP EPS of $1.36 beats by $0.04, revenue of $54.69M beats by $10.22M

LAKEWOOD, Colo., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for its third fiscal quarter (“3Q22”) and nine months ended December 31, 2021. Financial highlights for the quarter and nine months ended December 31, 2021 ...

Mesa Laboratories (NASDAQ:MLAB): Q2 Non-GAAP EPS of $1.87 beats by $0.80; GAAP EPS of $0.70 beats by $0.45. Revenue of $35.84M (+12.5% Y/Y) beats by $0.61M. Press Release For further details see: Mesa Laboratories EPS beats by $0.80, beats on revenue